Brookfield Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Brookfield Corp's AMGN Position: Q3 2023 in Review
Brookfield Corp sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,130 shares — an estimated $251K sold.
Brookfield Corp first reported a position in AMGN in Q4 2021 and held it in 5 quarters. The position peaked at $11.3M in Q1 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Brookfield Corp reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Brookfield Corp sold 1,130 Amgen shares in Q3 2023, an estimated $251K.
- Brookfield Corp first reported a position in Amgen in Q4 2021 and held it in 5 quarters.
- Brookfield Corp's Amgen position peaked at $11.3M in Q1 2022.
- 2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.